Dr. Erica Schwartz faces scrutiny during her CDC nomination hearings as she navigates questions about vaccine policy autonomy under Robert F. Kennedy Jr.'s leadership. Her appointment would mark the fourth directorship change at the Centers for Disease Control in less than two years, following the swift dismissal of her predecessor. The hearing highlights ongoing tensions between federal health institutions and the incoming administration's vaccine stance.

Summary auto-generated by AI from the original publisher's content. Editorial standards.